Verrica Pharmaceuticals Reports Q3 2024 Financials and Restructuring Plans
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) released its third-quarter financial results for 2024, unveiling a strategic restructuring plan to reduce expenses and improve market access for its …
Verrica Pharmaceuticals Reports Q3 2024 Financials and Restructuring Plans Read More